AgeX Therapeutics, Inc. announced that Michael H. May, has joined its Board of Directors. Dr. May fills a recent vacancy on the Board for an independent member, following the departure of Michael Mulroy, which was not because of a disagreement with AgeX on any matter relating to company operations, policies, or practices. Dr. May is President and CEO of Canada’s Centre for Commercialization of Regenerative Medicine (CCRM).